Envista Holdings Co. (NYSE:NVST) Shares Sold by Price T Rowe Associates Inc. MD

Price T Rowe Associates Inc. MD lowered its stake in shares of Envista Holdings Co. (NYSE:NVST - Free Report) by 16.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 118,464 shares of the company's stock after selling 22,508 shares during the quarter. Price T Rowe Associates Inc. MD owned 0.07% of Envista worth $2,286,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently bought and sold shares of NVST. Franklin Resources Inc. grew its holdings in shares of Envista by 72.6% during the fourth quarter. Franklin Resources Inc. now owns 6,854,506 shares of the company's stock worth $132,223,000 after purchasing an additional 2,882,844 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in Envista by 19.2% in the 4th quarter. Dimensional Fund Advisors LP now owns 6,762,091 shares of the company's stock valued at $130,440,000 after buying an additional 1,089,923 shares during the period. Massachusetts Financial Services Co. MA lifted its position in Envista by 9.5% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 3,271,175 shares of the company's stock valued at $63,101,000 after purchasing an additional 283,415 shares during the period. Charles Schwab Investment Management Inc. boosted its holdings in Envista by 8.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,317,631 shares of the company's stock valued at $44,707,000 after purchasing an additional 179,600 shares in the last quarter. Finally, Norges Bank acquired a new position in Envista during the 4th quarter worth approximately $38,052,000.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on NVST shares. Needham & Company LLC restated a "hold" rating on shares of Envista in a research note on Thursday, March 6th. Robert W. Baird set a $21.00 target price on shares of Envista in a research report on Friday, May 2nd. UBS Group dropped their target price on shares of Envista from $21.00 to $18.00 and set a "neutral" rating for the company in a report on Monday, May 5th. Morgan Stanley set a $16.00 price target on shares of Envista in a research report on Tuesday, April 15th. Finally, Piper Sandler decreased their target price on shares of Envista from $18.00 to $17.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 30th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, Envista presently has an average rating of "Hold" and a consensus price target of $20.08.

Envista Trading Up 4.9%

Shares of NYSE NVST traded up $0.86 during trading on Monday, hitting $18.45. 641,898 shares of the company traded hands, compared to its average volume of 2,521,315. The firm has a market capitalization of $3.13 billion, a P/E ratio of -2.86, a P/E/G ratio of 1.27 and a beta of 0.97. The company has a quick ratio of 1.76, a current ratio of 2.04 and a debt-to-equity ratio of 0.44. The company has a 50-day moving average price of $16.48 and a 200-day moving average price of $19.00. Envista Holdings Co. has a 1 year low of $14.22 and a 1 year high of $23.00.

Envista (NYSE:NVST - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The company reported $0.24 EPS for the quarter, beating the consensus estimate of $0.20 by $0.04. Envista had a negative net margin of 44.56% and a positive return on equity of 3.86%. The firm had revenue of $616.90 million for the quarter, compared to analyst estimates of $608.17 million. During the same quarter last year, the firm posted $0.26 earnings per share. Envista's revenue for the quarter was down 1.1% compared to the same quarter last year. On average, equities analysts predict that Envista Holdings Co. will post 1 EPS for the current year.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.